Daisy A. Hoagland
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
- Neurology top 1%
- Immunology top 5%
- interferon and immune responses 1
- Biological Psychiatry top 10%
- Sensory Systems top 5%
- Olfactory and Sensory Function Studies 1
-
- Biochemical Analysis and Sensing Techniques 1
-
- Single-cell and spatial transcriptomics 1
- CRISPR and Genetic Engineering 1
-
- Influenza Virus Research Studies 1
- Co-authors
- Benjamin R. tenOeverTristan X. JordanSkyler UhlDaniel Blanco-MeloJean K. LimMaryline PanisDavid SachsRasmus Møller
- Partner nations
- United States
In The Last Decade
Daisy A. Hoagland
4 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Infectious Diseases 2.3k
- Neurology 908
- Immunology 812
- Biological Psychiatry 57
- Sensory Systems 109
Countries citing papers authored by Daisy A. Hoagland
This map shows the geographic impact of Daisy A. Hoagland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisy A. Hoagland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisy A. Hoagland more than expected).
Fields of papers citing papers by Daisy A. Hoagland
This network shows the impact of papers produced by Daisy A. Hoagland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisy A. Hoagland. The network helps show where Daisy A. Hoagland may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daisy A. Hoagland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmiabreakdown → | 2022 | 168 |
| 3 | 2021 | 105 | |
| 4 | 2020 | 348 | |
| 5 | Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19breakdown → | 2020 | 2664 |
About Daisy A. Hoagland
Daisy A. Hoagland is a scholar working on Sensory Systems, Infectious Diseases and Immunology, having authored 5 papers that have together received 3.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), COVID-19 Clinical Research Studies (2 papers), interferon and immune responses (1 paper), Biochemical Analysis and Sensing Techniques (1 paper), Single-cell and spatial transcriptomics (1 paper), CRISPR and Genetic Engineering (1 paper), Olfactory and Sensory Function Studies (1 paper) and Influenza Virus Research Studies (1 paper). The work is most often cited by research in Infectious Diseases (2.3k citations), Neurology (908 citations) and Immunology (812 citations). Daisy A. Hoagland has collaborated with scholars based in United States. Frequent co-authors include Benjamin R. tenOever, Tristan X. Jordan, Skyler Uhl, Daniel Blanco-Melo, Jean K. Lim, Maryline Panis, David Sachs, Rasmus Møller, Kohei Oishi and Wen‐Chun Liu. Their work appears in journals such as Cell, Journal of Visualized Experiments and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.